Since activation of FAK and ERK1/2 was inhibited by UP-7 in HUVECs, we tested whether UP-7 is able to inhibit activation of FAK and ERK1/2 in NCI-H460 and LM-MDA-MB-231 cancer cells. The gene discussed is MAPK3; the disease is cancer.